CA3256966A1 - Peptide derivatives of sycamore and their methods of use - Google Patents

Peptide derivatives of sycamore and their methods of use

Info

Publication number
CA3256966A1
CA3256966A1 CA3256966A CA3256966A CA3256966A1 CA 3256966 A1 CA3256966 A1 CA 3256966A1 CA 3256966 A CA3256966 A CA 3256966A CA 3256966 A CA3256966 A CA 3256966A CA 3256966 A1 CA3256966 A1 CA 3256966A1
Authority
CA
Canada
Prior art keywords
methods
same
peptide derivatives
serpin peptide
serpin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3256966A
Other languages
English (en)
French (fr)
Inventor
Cohava Gelber
Cyrille Gineste
Dana AUSTIN
Original Assignee
SERPIN PHARMA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERPIN PHARMA LLC filed Critical SERPIN PHARMA LLC
Publication of CA3256966A1 publication Critical patent/CA3256966A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3256966A 2022-04-29 2023-04-27 Peptide derivatives of sycamore and their methods of use Pending CA3256966A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263363840P 2022-04-29 2022-04-29
US63/363,840 2022-04-29
PCT/US2023/066321 WO2023212661A1 (en) 2022-04-29 2023-04-27 Serpin peptide derivatives and methods of using the same

Publications (1)

Publication Number Publication Date
CA3256966A1 true CA3256966A1 (en) 2023-11-02

Family

ID=88519894

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3256966A Pending CA3256966A1 (en) 2022-04-29 2023-04-27 Peptide derivatives of sycamore and their methods of use

Country Status (9)

Country Link
US (1) US20250353898A1 (https=)
EP (1) EP4514838A1 (https=)
JP (1) JP2025515349A (https=)
CN (1) CN119497719A (https=)
AU (1) AU2023260921A1 (https=)
CA (1) CA3256966A1 (https=)
IL (1) IL316583A (https=)
MX (1) MX2024013323A (https=)
WO (1) WO2023212661A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439829A (en) * 1991-01-30 1995-08-08 Eli Lilly And Company Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
CN102731626B (zh) * 2011-04-13 2014-10-01 中国人民解放军军事医学科学院毒物药物研究所 环肽及其医药用途
CA3077804C (en) * 2012-01-09 2023-07-25 Serpin Pharma, Llc Peptides and methods of using same
WO2013172954A1 (en) * 2012-05-17 2013-11-21 Ra Pharmaceuticals, Inc Peptide and peptidomimetic inhibitors
WO2016154041A1 (en) * 2015-03-20 2016-09-29 University Of Florida Research Foundation Incorporated Serpin reactive center loop peptides and methods of use
WO2021219896A1 (en) * 2020-05-01 2021-11-04 Atlas Biotechnology S.A. Treatment and/or prevention of a disease or a syndrome related to a virus infection
EP4003391A4 (en) * 2020-07-06 2023-02-22 Serpin Pharma, LLC PEPTIDES AND METHODS OF USE THEREOF

Also Published As

Publication number Publication date
EP4514838A1 (en) 2025-03-05
WO2023212661A1 (en) 2023-11-02
CN119497719A (zh) 2025-02-21
US20250353898A1 (en) 2025-11-20
AU2023260921A1 (en) 2024-11-07
MX2024013323A (es) 2024-12-06
JP2025515349A (ja) 2025-05-14
IL316583A (en) 2024-12-01

Similar Documents

Publication Publication Date Title
EP4269428A4 (en) NEW PEPTIDE AND ITS USE
HK40121384A (en) Serpin peptide derivatives and methods of using the same
CA3256966A1 (en) Peptide derivatives of sycamore and their methods of use
EP4163288A4 (en) NEW NUCLEOLIN-BINDING PEPTIDE AND USE THEREOF
HK40111751A (en) Serpin peptides and methods of using the same
AU2024207151A1 (en) Anti-tnfr2 antigen-binding proteins and uses thereof
AU2021371342A9 (en) Peptides and methods of use
EP4236982A4 (en) PEPTIDES AND METHODS OF USE
CA3277627A1 (en) Peptide and use thereof
HK40127579A (en) Peptide-based delivery agent and method of making and using the same
CA3262709A1 (en) Peptide-based administration agent and its process of manufacture and use
CA3287113A1 (en) Trop2-binding proteins and uses thereof
AU2024272693A1 (en) Methanolytic agents and methods of using the same
CA3291343A1 (en) Methanolytic agents and methods of using the same
CA3262219A1 (en) EMOPAMIL-BINDING PROTEIN (EBP) INHIBITORS AND THEIR USES
HK40120710A (en) Emopamil-binding protein inhibitors and uses thereof
HK40120400A (en) Bicyclic-heterocycle derivatives and related uses
CA3271150A1 (en) Substituted phenylbenzenesulfonamide derivatives and uses thereof
CA3295221A1 (en) Statin derivatives and methods of using the same
HK40129300A (en) Lyophilized formulation of crofelemer and methods of treatment using the same
CA3265592A1 (en) LYOPHILIZED FORMULATION OF CROFELEMER AND PROCESSING METHODS USING IT
CA3298890A1 (en) Cryoprecipitate systems and methods of using the same
AU2025905146A0 (en) Peptides and uses thereof
HK40116989A (en) Oxoisoindolinyl-substituted tetrahydropyrimidinedione derivative and use thereof
HK40128877A (en) Cyclopentylpyrazolamine derivative and use thereof

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20241029

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250220

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250220

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250221

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-P145 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: BSL VERIFIED - DEFECT(S)

Effective date: 20250401

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250401

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED

Effective date: 20250414

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250414

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250702

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250708

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251014

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251205

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251205

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20260126

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260126

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260126

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260224